@article{5d9e65cf428944f6889a8ce4a078ac81,
title = "Interrogating the enhancer landscape of intracranial ependymomas: perspectives for precision medicine",
keywords = "Drug targets, enhancers, ependymoma, epigenomics, precision medicine",
author = "Konstantin Okonechnikov and Mack, \{Stephen C.\} and Marcel Kool and Pfister, \{Stefan M.\} and Pajtler, \{Kristian W.\}",
note = "Funding Information: This article was funded by Hopp-Children{\textquoteright}s Cancer Center at the NCT Heidelberg (KiTZ), German Cancer Research Center (DKFZ). Funding Information: K Okonechnikov, KW Pajtler, M Kool and SM Pfister were supported by Hopp-Children{\textquoteright}s Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany. SC Mack was supported by the Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.",
year = "2018",
month = may,
day = "4",
doi = "10.1080/23808993.2018.1467210",
language = "English",
volume = "3",
pages = "147--149",
journal = "Expert Review of Precision Medicine and Drug Development",
issn = "2380-8993",
publisher = "Taylor and Francis Ltd.",
number = "3",
}